United Kingdom precision
medicine market is expected to register robust growth in the forecast period,
2023-2027. Precision
medicine evaluates the genes and proteins which are present in the body of a
patient to design the personalized treatment drug to cure the specific disease.
With such discoveries including single nucleotide polymorphism and microarray/
biochips in the field of precision medicine, the market is projected to
experience a boom in the upcoming years. Continuous research activities on
human genome are the future of precision medicine and has a potential to upend
the medical treatment on individual patients by understanding their genetics,
molecular profiles, and clinical characteristics. The growing prevalence of
cancer is further escalating the demand for precision medicine for personalized
therapeutics and diagnostics which is positively influence the growth of the
market.
Growing Prevalence of CNS Disorders is
Projected to Augment the Market Growth
CNS ailments include Alzheimer’s
disease, multiple sclerosis, epilepsy, afflict millions of individuals across
the globe which is primarily driving the market growth. Dementia affects more
than 50 million individuals worldwide. Alzheimer's disease, the most common
kind of dementia, accounts for 60-70 percent of all cases. The growth of the
industry is aided by an enhancing focus on targeted therapeutics and the
development of individualized medical treatment regimens for persons suffering
from CNS illnesses.
Elevating Prevalence of Cancer Across
the United Kingdom Drives the Market Growth
The escalating demand for precision
medicine methods across the developed countries like UK owing to the rising
prevalence of cancer and the increasing number of treatment candidates in
clinical trials. This, turn, is driving the market growth. In addition to this,
the rising number of cases of genetic diseases will continue to influence
positively the growth of precision medicine market. With this, the elevating
levels of urbanization and inflating level of disposable income are
accelerating the growth of the precision medicine market. The growing
expenditure on healthcare infrastructure and expanding geriatric population are
the major market drivers that support the growth of precision medicine market.
The recent development in technologies including the ultra-high throughout
sequencing and next-generation sequencing is expected to fuel the growth of the
market over the future years.
Extensive R&D Activities is
Anticipated to Bolster the Market Growth
The growing number of research and
development activities offer lucrative opportunities for the precision medicine
market growth. The enhancing focus of manufacturers on the adoption of upgraded
technologies and rise in the number of emerging economies will opportunities
for the precision medicine market growth in the upcoming years.